T7650
3,3′,5-Triiodothyroacetic acid
≥90%
Manufacturer: Sigma Aldrich
CAS Number: 51-24-1
Synonym(S): 4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenylacetic acid
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 100 MG | T7650-100-MG | In Stock | ₹ 9,731.68 |
| 500 MG | T7650-500-MG | In Stock | ₹ 20,599.98 |
| 1 G | T7650-1-G | In Stock | ₹ 37,703.48 |
T7650 - 100 MG
In Stock
Quantity
1
Base Price: ₹ 9,731.68
GST (18%): ₹ 1,751.702
Total Price: ₹ 11,483.382
Quality Level
200
Assay
≥90%
form
powder
storage temp.
−20°C
SMILES string
OC(=O)Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1
InChI
1S/C14H9I3O4/c15-9-6-8(1-2-12(9)18)21-14-10(16)3-7(4-11(14)17)5-13(19)20/h1-4,6,18H,5H2,(H,19,20)
InChI key
UOWZUVNAGUAEQC-UHFFFAOYSA-N
Gene Information
human ... THRA(7067) , THRB(7068) rat ... Thra(81812) , Thrb(24831)
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
Sigma Aldrich Fine Chemicals Biosciences 3,3',5-Triiodothyroacetic acid >=90% | 51-24-1 | MFCD00055931 | 500MG | -- | ₹ 40,012.62 | ||
Sigma Aldrich Fine Chemicals Biosciences 3,3',5-Triiodothyroacetic acid >=90% | 51-24-1 | MFCD00055931 | 1G | -- | ₹ 67,107.78 | ||
Tiratricol | -- | ₹ 2,314.00 - ₹ 25,810.00 | ||
51-24-1 | 3,3',5-Triiodothyroacetic acid | -- | ₹ 445.00 - ₹ 25,810.00 |
Description
- Application: Thyroid hormone research: A study explored the impact of 3,3′,5-Triiodothyroacetic acid on peripheral and neurodevelopmental findings in patients with MCT8 deficiency, highlighting its potential in therapeutic interventions for thyroid-related developmental disorders (Unsal and Hayran, 2024).Neurological disorder management: Research demonstrated the use of 3,3′,5-Triiodothyroacetic acid in addressing impaired T3 uptake and action in cerebral organoids modeling Allan-Herndon-Dudley syndrome, providing insights into its application in managing brain-specific thyroid hormone transport abnormalities (Salas-Lucia et al., 2024).Pharmaceutical development for antiviral therapies: Tiratricol, a derivative of 3,3′,5-Triiodothyroacetic acid, was identified as an inhibitor of yellow fever virus replication by targeting the viral RNA-dependent RNA polymerase, showcasing its potential in antiviral drug development (Ren et al., 2023).
SAFETY INFORMATION
Pictograms
Signal Word
Warning
Hazard Statements
Precautionary Statements
P261 - P264 - P280 - P301 + P312 - P302 + P352 + P312 - P304 + P340 + P312
Hazard Classifications
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral
WGK
WGK 3